Skip to main content
. Author manuscript; available in PMC: 2017 Aug 11.
Published in final edited form as: Addiction. 2017 Feb 17;112(7):1290–1299. doi: 10.1111/add.13764

Figure 5.

Figure 5

Results of one-way sensitivity analysis showing the relative difference in CHC prevalence projected in 2030 for varying parameters of the model compared to the base parameter values in Table 1. A value of zero describes no change from the projected CHC prevalence in 2030 compared to the base scenario. A positive or a negative value means that the projected CHC prevalence is lower or higher, respectively, compared to that projected under the base scenario. The scenario of 332 annual antiviral treatments was used.